The role of novel biomarkers in predicting diabetic nephropathy: a review

References

• KoulouridisEDiabetic nephropathy in children and adolescents and its consequences in adultsJ Pediatr Endocrinol Metab200114Suppl 5S1367S1377
   PubMedGoogle Scholar
• UwaezuokeSNPrevention of diabetic nephropathy in children and adolescents: how effective are the current strategies?Int J Diabetol Vasc Dis Res2015 S5:00115
   Google Scholar
• DeferrariGRepettoMCalviCCiabattoniMRossiCRobaudoCDiabetic nephropathy: from micro- to microalbuminuriaNephrol Dial Transplant199813Suppl 8S11S15
   Google Scholar
• DanneTKordonouriOHövenerGWeberBDiabetic angiopathy in childrenDiabet Med19971412101210259455928
   PubMed Web of Science ®Google Scholar
• MaghribiHAbu-OdehAEarly diabetic nephropathy in a pediatric patientJRMS20061315153
   Google Scholar
• FrancisJRoseSJRaafatFMilfordDVEarly onset of diabetic nephropathyArch Dis Child19977765245259496190
   PubMed Web of Science ®Google Scholar
• DeClueTJCamposADiabetic nephropathy in a prepubertal diabetic femaleJ Pediatr Endocrinol19947143468186823
   PubMed Web of Science ®Google Scholar
• RemuzziGSchieppatiARuggenentiPNephropathy in patients with type 2 diabetesN Engl J Med2002346151145115111948275
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationPosition statement: diabetic nephropathyDiabetes Care199922Suppl 1S66S69
   Google Scholar
• CaramoriMLFiorettoPMauerMThe need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?Diabetes20004991399140810969821
   PubMed Web of Science ®Google Scholar
• PerkinsBAFicocielloLHSilvaKHFinkelsteinDMWarramJHKrolewskiASRegression of microalbuminuria in type 1 diabetesN Engl J Med2003348232285229312788992
   PubMed Web of Science ®Google Scholar
• GiorginoFLaviolaLCavallo PerinPSolnicaBFullerJChaturvediNFactors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications StudyDiabetologia20044761020102815170497
   PubMed Web of Science ®Google Scholar
• CaramoriMLFiorettoPMauerMEnhancing the predictive value of urinary albumin for diabetic nephropathyJ Am Soc Nephrol200617233935216394108
   PubMed Web of Science ®Google Scholar
• AdlerAIStevensRJManleySEBilousRWCullCAHolmanRRUKPDS GROUPDevelopment and progression of nephropathy in type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 64)Kidney Int200363122523212472787
   PubMed Web of Science ®Google Scholar
• AnJHChoYMYuHGThe clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complicationJ Korean Med Sci200924SupplS75S8119194567
   PubMed Web of Science ®Google Scholar
• MathesonAWillcoxMDPFlanaganJWalshBJUrinary biomarkers involved in type 2 diabetes: a reviewDiabetes Metab Res Rev201026315017120222150
   PubMed Web of Science ®Google Scholar
• AroraMKSinghUKMolecular mechanisms in the pathogenesis of diabetic nephropathy: an updateVascul Pharmacol201358425927123313806
   PubMed Web of Science ®Google Scholar
• WadaJMakinoHInflammation and the pathogenesis of diabetic nephropathyClin Sci (Lond)2013124313915223075333
   PubMed Web of Science ®Google Scholar
• TavridouAGeorgoulidouARoumeliotisAAssociation of plasma adiponectin and oxidized low-density lipoprotein with carotid intima-media thickness in diabetic nephropathyJ Diabetes Res2015201550726526064982
   PubMed Web of Science ®Google Scholar
• MatavelliLCHuangJSiragyHM(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammatoryClin Exp Pharmacol Physiol201037327728219769609
   PubMed Web of Science ®Google Scholar
• EgidoJVasoactive hormones and renal sclerosisKidney Int19964925785978821847
   PubMed Web of Science ®Google Scholar
• FeliersDGorinYGhosh-ChoudhuryGAbboundHEKasinathBSAngiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen speciesAm J Physiol Renal Physiol20062904927936
   Web of Science ®Google Scholar
• NakamuraSNakamuraIMaLVaughanDEFogoABPlasminogen activator inhibitor-1 (PAI-1) expression is regulated by the angiotensin type 1 receptor in vivoKidney Int200058125125910886570
   PubMed Web of Science ®Google Scholar
• Ruiz-OrtegaMRupérezMEstebanVAngiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseasesNephrol Dial Transplant2006211162016280370
   PubMed Web of Science ®Google Scholar
• KangYSParkYGKimBKAngiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytesJ Mol Endocrinol200636237738816595708
   PubMed Web of Science ®Google Scholar
• GiacchettiGSechiLARilliSCareyRMThe renin-angiotensin-aldosterone system, glucose metabolism and diabetesTrends Endo-crinol Metabol2005163120126
   PubMed Web of Science ®Google Scholar
• FujisawaGOkadaKMutoSSpironolactone prevents early renal injury in streptozotocin-induced diabetic ratsKidney Int20046641493150215458443
   PubMed Web of Science ®Google Scholar
• TairaMTobaHMurakamiMSpironolactone exhibits direct renoprotective effects and inhibits renin-angiotensin-aldosterone system in diabetic ratsEur J Pharmacol20085891–326427118582458
   PubMed Web of Science ®Google Scholar
• GuoCMartinez-VasquezDMendezGPMineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitusEndocrinology2006147115363537316901964
   PubMed Web of Science ®Google Scholar
• Thallas-BonkeVThorpeSRCoughlanMTInhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathwayDiabetes200857246046917959934
   PubMed Web of Science ®Google Scholar
• YaoLWangJMaoYZhuHDengAZhuZDifferent expressions of protein kinase C-alpha, beta I and beta II in glomeruli of diabetic nephropathy patientsJ Huazhong Univ Sci Technology Med Sci2006266651653
   Google Scholar
• XiaLWangHMunkSReactive oxygen species, PKC-beta I and PKC-zeta mediate high glucose-induced vascular endothelial growth factor expression in mesangial cellsAm J Physiol Endocrinol Metab20072935E1280E128817711990
   PubMed Web of Science ®Google Scholar
• KoyaDJirousekMRLinYWIshiiHKubokiKKingGICharacterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components and prostanoids in the glomeruli of diabetic ratsJ Clin Invest199710011151269202063
   PubMed Web of Science ®Google Scholar
• GorinYBlockKHernandezJNox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidneyJ Biol Chem200528047396163962616135519
   PubMed Web of Science ®Google Scholar
• XiaLWangHGoldbergHJMunkSFantusIGWhitesideCIMesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expressionAm J Physiol Renal Physiol20062902F345F35616131649
   PubMed Web of Science ®Google Scholar
• AsabaKTojoAOnozatoMLEffects of NADPH oxidase inhibitor in diabetic nephropathyKidney Int20056751890189815840036
   PubMed Web of Science ®Google Scholar
• ZugmaierGPaikSWildingGTransforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude miceCancer Res19915113359035942054795
   PubMed Web of Science ®Google Scholar
• MoriwakiYYamamotoTShbutaniYElevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathyMetabolism200352560560812759891
   PubMed Web of Science ®Google Scholar
• NiewczasMAGohdaTSkupienJCirculating TNF receptors 1 and 2 predict ESRD in type 2 diabetesJ Am Soc Nephrol201223350751522266663
   PubMed Web of Science ®Google Scholar
• NavarroJFMoraCMurosMGarciaJUrinary tumour necrosis-alpha excretion independently correlates with clinical markers of glomerular and tubulo-interstitial injury in type 2 diabetic patientsNephrol Dial Transplant200621123428343416935891
   PubMed Web of Science ®Google Scholar
• HaraldssonBNyströmJDeenWMProperties of the glomerular barrier and mechanisms of proteinuriaPhysiol Rev200888245148718391170
   PubMed Web of Science ®Google Scholar
• BirnHChristensenEIRenal albumin absorption in physiology and pathologyKidney Int200669344044916514429
   PubMed Web of Science ®Google Scholar
• Cohen-BucayAViswanathanGUrinary markers of glomerular injury in diabetic nephropathyInt J Nephrol2012201214698722645683
   PubMedGoogle Scholar
• de ZeeuwDRamjitDZhangZRenal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAALKidney Int20066991675168216572114
   PubMed Web of Science ®Google Scholar
• de ZeeuwDRemuzziGParvingHHAlbuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyCirculation2004110892192715302780
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes-2014Diabetes Care201437Suppl 1S14S8024357209
   PubMed Web of Science ®Google Scholar
• NinomiyaTPerkovicVde GalanBEADVANCE Collaborative GroupAlbuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesJ Am Soc Nephrol20092081813182119443635
   PubMed Web of Science ®Google Scholar
• DinneenSFGersteinHCThe association of microalbuminuria and mortality in none-insulin-dependent diabetes mellitus: a systematic overview of the literatureArch Int Med199715713141314189224218
   PubMed Web of Science ®Google Scholar
• RuggenentiPRemuzziGTime to abandon microalbuminuria?Kidney Int20067071214122216871239
   PubMed Web of Science ®Google Scholar
• GersteinHCMannJFYiQHOPE Study InvestigatorsAlbuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individualsJAMA2001286442142611466120
   PubMed Web of Science ®Google Scholar
• KlausenKBorch-JohnsenKFeldt-RasmussenBVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetesCirculation20041101323515210602
   PubMed Web of Science ®Google Scholar
• WachtellKIbsenHOlsenMHAlbuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE studyAnn Int Med20031391190190614644892
   PubMed Web of Science ®Google Scholar
• CurrieGMcKayGDellesCBiomarkers in diabetic nephropathy: present and futureWorld J Diabetes20145676377625512779
   PubMedGoogle Scholar
• BhensdadiaNMHuntKJLopes-VirellaMFVeterans Affairs Diabetes Trial (VADT) study groupUrine haptoglobin levels predict early renal functional decline in patients with type 2 diabetesKidney Int20138361136114323536133
   PubMed Web of Science ®Google Scholar
• MorescoRNSangoiMBDe CarvalhoJATatschEBochiGVDiabetic nephropathy: traditional to proteomic markersClin Chim Acta2013421173023485645
   PubMed Web of Science ®Google Scholar
• GluhovschiCGluhovschiGPetricaLUrinary biomarkers in the assessment of early diabetic nephropathyJ Diabetes Res20162016462612527413755
   PubMed Web of Science ®Google Scholar
• HongCYChiaKSMarkers of diabetic nephropathyJ Diabetes Complications199812143609442815
   PubMed Web of Science ®Google Scholar
• LeeSYChoiMEUrinary biomarkers for early diabetic nephropathy: beyond albuminuriaPediatr Nephrol20153071063107525060761
   PubMed Web of Science ®Google Scholar
• YangYXiaoLLiJKanwarYSLiuFSunLUrine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathyMed Hypotheses201381227427823683774
   PubMed Web of Science ®Google Scholar
• NaritaTHosobaMMiuraTLow dose of losartan decreased urinary excretions of IgG, transferrin, and ceruloplasmin without reducing albuminuria in normoalbuminuric type 2 diabetic patientsHorm Metab Res200840429229518548390
   PubMed Web of Science ®Google Scholar
• CheungCKCockramCSYeungVTSwaminathanRUrinary excretion of transferrin by non-insulin-dependent diabetics: a marker for early complications?Clin Chem1989358167216742758634
   PubMed Web of Science ®Google Scholar
• MartinPWaltonCChapmanCBodanskyHJSticklandMHIncreased urinary excretion of transferrin in children with type 1 diabetes mellitusDiabet Med19907135401688749
   PubMed Web of Science ®Google Scholar
• O’DonnellMJMartinPFlorkowskiCMUrinary transferrin excretion in type 1 (insulin-dependent) diabetes mellitusDiabet Med1991876576611833118
   PubMed Web of Science ®Google Scholar
• BernardAMAmorAAGoemaere-VannesteJMicrotransferrinuria is a more sensitive indicator of early glomerular damage in diabetes than microalbuminuriaClin Chem198834919201921
   PubMed Web of Science ®Google Scholar
• O’DonnellMJMartinPCavanDIncreased urinary transferrin excretion in exercising normoalbuminuric insulin-dependent diabetic patientsAnn Clin Biochem199128Pt 54564601720297
   PubMed Web of Science ®Google Scholar
• McCormickCPKonenJCShihabiZKMicrotransferrinuria and microalbuminuria: in the diabetic humanClin Physiol Biochem1989825358
   Google Scholar
• KazumiTHozumiTIshidaYIncreased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetesDiabetes Care19992271176118010388985
   PubMed Web of Science ®Google Scholar
• NaritaTHosobaMKakeiMItoSIncreased urinary excretions of immunoglobulin G, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetesDiabetes Care200629114214416373913
   PubMed Web of Science ®Google Scholar
• SasakiAOikawaSToyotaTMicroalbuminuria is closely related to diabetic macroangiopathyDiabetes Res Clin Pract1999441354010414938
   PubMed Web of Science ®Google Scholar
• BernardAAmorAOGoemare-VannesteJUrinary proteins and red blood cell membrane negative charges in diabetes mellitusClin Chim Acta199019032492622253403
   PubMed Web of Science ®Google Scholar
• MartinPTindallHHarveyJNHandleyTMChapmanCDaviesJAGlomerular and tubular proteinuria in type 1 (insulin-dependent) diabetic patients with and without retinopathyAnn Clin Biochem199229Pt 32652701376979
   PubMed Web of Science ®Google Scholar
• YaqoobMMcClellandPPatrickAWStevensonAMasonHBellGMTubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathyRen Fail199517143497770643
   PubMed Web of Science ®Google Scholar
• NaritaTSasakiHHosobaMParallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patientsDiabetes Care20042751176118115111541
   PubMed Web of Science ®Google Scholar
• WangCLiCGongWLouTNew urinary biomarkers for diabetic kidney diseaseBiomarker Res201319
   Google Scholar
• KotajimaNKimuraTKandaTType IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitusJ Diabetes Complications2000141131710925061
   PubMed Web of Science ®Google Scholar
• TanYYangYZhangZZhangXLiuYUrinary type IV collagen: a specific indicator of incipient diabetic nephropathyChin Med J (Engl)2002115338939411940372
   PubMed Web of Science ®Google Scholar
• KadoSAokiAWadaSUrinary type IV collagen as a marker for early diabetic nephropathyDiabetes Res Clin Pract1996311–31031088792108
   PubMed Web of Science ®Google Scholar
• BanuNHaraHOkamuraMEgusaGYamakidoMUrinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damageDiabetes Res Clin Pract199529157678593760
   PubMed Web of Science ®Google Scholar
• SthaneshwarPChanSPUrinary type IV collagen levels in diabetes mellitusMalays J Pathol2010321434720614725
   PubMedGoogle Scholar
• IijimaTSuzukiSSekizukaKFollow-up study on urinary type IV collagen in patients with early stage diabetic nephropathyJ Clin Lab Anal19981263783829850190
   PubMed Web of Science ®Google Scholar
• HaiyashiYMakinoHOtaZSerum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetesDiabet Med1992943663701600709
   PubMed Web of Science ®Google Scholar
• MiyakeHNagashimaKYagiHOnigataKUrinary laminin P1 as an index of glycemic control in children with insulin-dependent diabetes mellitusDiabetes Res1992233131138
   Google Scholar
• TakahashiMIncreased urinary fibronectin excretion in type II diabetic patients with microalbuminuriaNihon Jinzo Gakkai Shi19953763363427666599
   PubMedGoogle Scholar
• FageruddJAGroopPHHonkanenETeppoAMGrönhagen-RiskaCUrinary excretion of TGF-β1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patientsKidney Int19975163S195S197
   Google Scholar
• KanauchiMNishiokaHHashimotoTDohiKDiagnostic significance of urinary transferrin in diabetic nephropathyNihon Jinzo Gakkai Shi199537116496548583702
   PubMedGoogle Scholar
• KubokiKTadaHShinKOshimaYIsogaiSRelationship between urinary excretion of fibronectin degradation products and proteinuria in diabetic patients, and their suppression after continuous subcutaneous heparin infusionDiabetes Res Clin Pract199321161668253024
   PubMed Web of Science ®Google Scholar
• UetaITakamatsuKHashimotoKUrinary glycosaminoglycans in patients with incipient diabetic nephropathyNihon Jinzo Gakkai Shi199537117237699949
   PubMedGoogle Scholar
• TorffvitOUrinary sulphated glycosaminoglycans and Tamm-Horsfall protein in type 1 diabetic patientsScand J Urol Nephrol199933532833210572998
   PubMed Web of Science ®Google Scholar
• UeharaYMakinoHSeikiKUradeYL-PGDS Clinical Research Group of KidneyUrinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multi-center studyNephrol Dial Transplant200924247548218799608
   PubMed Web of Science ®Google Scholar
• MiseKHoshinoJUenoTPrognostic value of tubulointerstitial lesions, urinary N-acetyl-β-d-glucosaminidase, and urinary β2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathyClin J Am Soc Nephrol201611459360126801478
   PubMed Web of Science ®Google Scholar
• FisehaTUrinary biomarkers for early diabetic nephropathy in type 2 diabetic patientsBiomark Res2015311626146561
   PubMedGoogle Scholar
• BolignanoDLacquanitiACoppolinoGNeutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patientsKidney Blood Press Res2009322919819321980
   PubMed Web of Science ®Google Scholar
• Yürük YıldırımZNayırAYılmazAGedikbasıABundakRNeutrophil gelatinase-associated lipocalin as an early sign of diabetic kidney injury in childrenJ Clin Res Pediatr Endocrinol20157427427926777038
   PubMed Web of Science ®Google Scholar
• LacquanitiADonatoVPintaudiB“Normoalbuminuric” diabetic nephropathy: tubular damage and NGALActa Diabetol201350693594223754672
   PubMed Web of Science ®Google Scholar
• de CarvalhoJATatschEHausenBSUrinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetesClin Biochem201649323223626519090
   PubMed Web of Science ®Google Scholar
• YangYHHeXJChenSRWangLLiEMXuLYChanges of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up studyEndocrine2009361455119390997
   PubMed Web of Science ®Google Scholar
• HongCYHughesKChiaKSNgVLingSLUrinary alpha1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in SingaporeDiabetes Care200326233834212547859
   PubMed Web of Science ®Google Scholar
• WainaiHKatsukawaFTakeiIMaruyamaHKataokaKSarutaTInfluence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitusJ Diabetes Complications199152–3160161
   Google Scholar
• ShoreNKhurshidRSaleemMAlpha-1microglobulin: a marker for early detection of tubular disorders in diabetic nephropathyJ Ayub Med Coll Abbottabad20102245355
   Google Scholar
• PatelDNKaliaKEfficacy of urinary N-acetyl-β-D glucosaminidase to evaluate early renal tubular damage as a consequence of type 2 diabetes mellitus: a cross-sectional studyInt J Diabetes Dev Ctries201535Suppl 3449457
   Web of Science ®Google Scholar
• AssalHSTawfeekSRasheldEAEl-LebedyDThabetEHSerum cystatin C and tubular urinary enzymes as biomarkers: a renal dysfunction in type 2 diabetes mellitusClin Med Insights Endocrinol Diabetes2013671323966807
   PubMedGoogle Scholar
• AmbadeVSinghPSomaniBLBasannarDUrinary N-acetyl β-glucosaminidase and γ-glutamyl transferase as early markers of diabetic nephropathyIndian J Clin Biochem2006212142148
   Google Scholar
• JonesAPLockSGriffithsKDUrinary N-acetyl-β-glucosaminidase activity in type I diabetes mellitusAnn Clin Biochem199532Pt 158627762951
   PubMed Web of Science ®Google Scholar
• GargVKumarMMahapatraHSChitkaraAGadpayleAKSekharVNovel urinary biomarkers in pre-diabetic nephropathyClin Exp Nephrol201519589590025634253
   PubMed Web of Science ®Google Scholar
• KimSSSongSHKimIJUrinary cystatin C and tubular proteinuria predict progression of diabetic nephropathyDiabetes Care201336365666123093662
   PubMed Web of Science ®Google Scholar
• JeonYKKimMRHuhJECystatin C as an early biomarker of nephropathy in patients with type 2 diabetesJ Korean Med Sci201126225826321286018
   PubMed Web of Science ®Google Scholar
• BonventreJVKidney injury molecule-1: a translational journeyTrans Am Clin Climatol Assoc201412529329925125746
   PubMedGoogle Scholar
• PetricaLVladAGluhovschiGProximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional studyPLoS One2014911e11253825397960
   PubMed Web of Science ®Google Scholar
• NielsenSESugayaTHovindPBabaTParvingH-HRossingPUrinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsDiabetes Care20103361320132420185732
   PubMed Web of Science ®Google Scholar
• Kamijo-IkemoriASugayaTYasudaTClinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patientsDiabetes Care201134369169621273494
   PubMed Web of Science ®Google Scholar
• PanduruNMForsblomCSaraheimoMFinnDiane Study GroupUrinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetesDiabetes Care20133672077208323378622
   PubMed Web of Science ®Google Scholar
• ElmarakbyAASullivanJCRelationship between oxidative stress and inflammatory cytokines in diabetic nephropathyCardiovasc Ther2012301495920718759
   PubMed Web of Science ®Google Scholar
• NavarroJFMoraCDiabetes, inflammation, proinflammatory cytokines, and diabetic nephropathyScientificWorldJournal2006690891716906324
   PubMed Web of Science ®Google Scholar
• HasegawaGNakanoKSawadaMPossible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathyKidney Int1991406100710121762301
   PubMed Web of Science ®Google Scholar
• OrtizAGonzález-CuadradoSBustosCTumor necrosis factor as a mediator of glomerular damageJ Nephrol199582734
   Web of Science ®Google Scholar
• BertaniTAbbateMZojaCTumor necrosis factor induces glomerular damage in rabbitAm J Pathol198913424194302916653
   PubMed Web of Science ®Google Scholar
• KalantariniaKAwasASSiragyHMUrinary and renal interstitial concentrations of TNF-α increase prior to the rise in albuminuria in diabetic ratsKidney Int20036441208121312969138
   PubMed Web of Science ®Google Scholar
• NavarroJFMoraCMacaMGarcaJInflammatory parameters are independently associated with urinary albumin excretion in type 2 diabetes mellitusAm J Kidney Dis2003421536112830456
   PubMed Web of Science ®Google Scholar
• NavarroJFMoraCRiveroAUrinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administrationAm J Kidney Dis199933345846310070909
   PubMed Web of Science ®Google Scholar
• NakamuraAShikataKHiramatsuMSerum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetesDiabetes Care200528122890289516306550
   PubMed Web of Science ®Google Scholar
• KajitaniNShikataKNakamuraANakatouTHiramatsuMMakinoHMicroinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetesDiabetes Res Clin Pract201088217117620138680
   PubMed Web of Science ®Google Scholar
• PerlmanASChevalierJMWilkinsonPSerum inflammatory and immune mediators are elevated in early stage diabetic nephropathyAnn Clin Lab Sci201545325626326116588
   PubMed Web of Science ®Google Scholar
• HarRScholeyJWDanemanDThe effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitusDiabetologia20135651166117323412605
   PubMed Web of Science ®Google Scholar
• Van CoillieEVan DammeJOpdenakkerGThe MCP/eotaxin subfamily of chemokinesCytokine Growth Factor Rev1999101618610379912
   PubMed Web of Science ®Google Scholar
• TashiroKKoyanagiISaitohAUrinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL8), and renal injuries in patients with type 2 diabetic nephropathyJ Clin Lab Anal20021611411835523
   PubMed Web of Science ®Google Scholar
• LiuJZhaoZWillcoxMDXuBShiBMultiplex bead analysis of urinary cytokines of type 2 diabetic patients with normo- and microalbuminuriaJ Immunoassay Immunochem201031427928921113841
   PubMed Web of Science ®Google Scholar
• JiangHGuanGZhangRIncreased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathyNephrology200914333233719143942
   PubMed Web of Science ®Google Scholar
• ZoppiniGTargherGChoncholMPredictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney functionClin J Am Soc Nephrol20127340140822282481
   PubMed Web of Science ®Google Scholar
• WuLLChiouCCChangPYWuJTUrinary 8OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabeticsClin Chem Acta20043391–219
   PubMed Web of Science ®Google Scholar
• HinokioYSuzukiSHiraiMSuzukiCSuzukiMToyotaTUrinary excretion of 8-oxo-7,8-dihydro-2-deoxyguanosine as a predictor of the development of diabetic nephropathyDiabetologia200245687788212107732
   PubMed Web of Science ®Google Scholar
• KellyDJAaltonenPCoxAJExpression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of antiproteinuric therapiesNephrol Dial Transplant20021771327133212105259
   PubMed Web of Science ®Google Scholar
• LanghamRGKellyDJCoxAJProteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibitionDiabetologia200245111572157612436341
   PubMed Web of Science ®Google Scholar
• PätäriAForsblomCHavanaMTaipaleHGroopPHHolthöferHNephrinuria in diabetic nephropathy of type 1 diabetesDiabetes200352122969297414633858
   PubMed Web of Science ®Google Scholar
• NgDPTaiBCTanENephrinuria associates with multiple renal traits in type 2 diabetesNephrol Dial Transplant20112682508251421196468
   PubMed Web of Science ®Google Scholar
• KimNHKimKBKimDLPlasma and urinary vascular endothelial growth factor and diabetic nephropathy in type 2 diabetes mellitusDiabet Med200421654555115154937
   PubMed Web of Science ®Google Scholar
• ShojiMKobayashiKTakemotoMSatoYYokoteKUrinary podocalyxin levels were associated with urinary albumin levels among patients with diabetesBiomarkers201521216416726635084
   PubMed Web of Science ®Google Scholar
• TurkNMornarAMrzljakVTurkZUrinary excretion of advanced glycation end products in patients with type 2 diabetes and various stages of proteinuriaDiabetes Metab200430218719215223992
   PubMed Web of Science ®Google Scholar